Developed by Qatar Biomedical Research Institute and Hamad Bin Khalifa University, this innovative eye-tracking technology supports early identification of autism in Arabic-speaking children. Using remote eye-tracking, the system measures gaze patterns in response to specific visual stimuli, enabling detection of autism spectrum disorder through objective data analysis rather than relying solely on behavioral observation.

Adapted from clinically validated stimuli developed in collaboration with Cleveland Clinic, the technology compiles gaze data into an autism risk index, offering a user-friendly screening and diagnostic tool for children aged 3 to 15 years. With a reported accuracy rate exceeding 87%, it provides families, clinicians, and researchers with a timely and efficient screening and diagnostic solution.

By addressing the need for culturally and linguistically appropriate tools in Arabic-speaking communities, this approach makes early detection more accessible. It represents a meaningful advancement in autism screening and diagnosis, combining scientific rigor with practical, real-world application. Autism-I-Track now a registered company which will be licensed and used by clinics, hospitals, and autism centers in Qatar, GCC, and other parts of the world.